support this Website with an
unrestricted educational grant.
About EURAMOS
EURAMOS is the European and American Osteosarcoma Study Group. The study was founded in 2001.
This website contains information about Osteosarcoma and the current EURAMOS I Trial.
To read more about EURAMOS click here.
If you have any questions regarding the EURAMOS 1 trial or any difficulties using this website, please contact euramos1@ctu.ac.uk
What's New?
Pan European Clinical Trials under current EU regulations: A training course for data managers, study nurses and junior clinical investigators.
24-25 January 2008, the Selsdon Park Hotel, South Croydon, London.
To read more about the training course and to view the presentations click here.
Bringing Medicine to Life: Images from the Art Project are on permanent display at the Wellcome Trust 'Medicine Now' Gallery, located on the first floor of Wellcome Collection Conference Centre, 183 Euston Road, London
Click here to read more about the Art Project.
A project inspired by the MRC Clinical Trials Unit in collaboration with Dr Martha Perisoglou in the University College Hospital, London.
Members
New Applicant Countries
New applicant countries wishing to join the EURAMOS collaboration should read the National Application guidelines. This document describes the process for applicant countries wishing to join the EURAMOS collaboration, and the steps taken by the EURAMOS groups to assess the application and how to implement new countries and associated Institutions to the EURAMOS study.
Click here to view the National Application guidelines in PDF format
Click here to view the National Application guidelines in word format
Participating Instituitions
Participating Instituitions in EURAMOS I can access detailed trial information through the password-protected members sections.
Click here to access the Participating Instituitions section.
Trial Management Group
Trial Management Group members can all the documents in the members' password-protected sections
To access the Trial Management Group section Click here.
In focus
Scandinavian Sarcoma Group (SSG)
The Scandinavian Sarcoma Group (SSG) comprises the Scandinavian countries (Denmark, Finland, Iceland, Norway and Sweden) with a population of about 25 million people.
Since 1979, SSG has performed three non-randomized neo-adjuvant chemotherapy trials for high-grade osteosarcoma localized to the extremities.
Our Collaborators
